The PolyNovo Ltd (ASX: PNV) share price is pushing higher this morning following the release of a couple of positive announcements.
At the time of writing, the medical device company’s shares are up 7% to $2.66.
What did PolyNovo announce?
This morning PolyNovo announced that it has expanded its presence in Europe by entering into both the Poland and Turkey markets.
In respect to Poland, the company has appointed Hortho Medical Innovations as its exclusive distributor in the country.
According to the release, Hortho distributes modern and innovative devices for medical reconstruction. This includes a number of complementary bio-absorbable implant technologies.
It also works closely with key opinion leaders in plastic/reconstructive surgery and has a direct team servicing all of Poland. Hortho plans to add dedicated personnel to support NovoSorb BTM sales and marketing activities.
The company notes that Poland is the sixth largest country in the European Union with a population of more than 38 million, and a medical device market valued at over $2.2 billion.
PolyNovo’s Managing Director, Paul Brennan, said: “Poland is an exciting growth market in Europe and we see this partnership as an important step in expanding our sales in Europe.”
What about Turkey?
Over in Turkey, PolyNovo has appointed Incomed Saglik Hiz and its medical sales channel LotuS as its distributor.
It notes that this expansion into the Europe-Middle East-Africa (EMEA) region is a big step in bringing NovoSorb BTM to a significant number of surgeons and patients in the region.
LotuS has an established product portfolio and sales relationships within wound and burn treatment. It also has over 10 years’ experience launching innovative devices through its extensive customer base.
Management advised that LotuS is the distributor of Suprathel (an artificial wound and burn dressing) and is familiar with the benefits of synthetic products in the treatment of complex surgical wounds. NovoSorb BTM will complete its plastic and reconstructive surgery offering.
Mr Brennan commented: “We are excited by our partnership with LotuS mcd and our entry into Turkey. The country is an important geographical and commercial link in our European, Mediterranean and Middle East strategy. We will now be able to service surgeons who work across EMEA and expand the inter-surgeon referral of the benefits of NovoSorb BTM.”
This Tiny ASX Stock Could Be the Next Afterpay
One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!
See how you can find out the name of this stock
Returns as of 6th October 2020
More reading
- ASX 200 Weekly Wrap: ASX drops despite promises of more US stimulus
- These were the worst performing ASX 200 shares last week
- Why Advance Nanotek, Polynovo, Resolute, & Tyro shares are dropping lower
- ASX 200 up 0.4%: Afterpay hits record high, bank shares rise, Resolute disappoints
- Why this broker sees little upside to the Polynovo (ASX:PNV) share price right now
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Why the PolyNovo (ASX:PNV) share price is zooming 7% higher today appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3sH4XjF
Leave a Reply